Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500095761Phase 4Not yet recruiting
Phase 4, open-label trial of human rabies vaccine and Rabies vaccine in rabies (2 arms), sponsored by Third People's Hospital of Chengdu. Primary endpoint: Adverse events within 3 days from first dose to completion of full immunization. Planned start Jan 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500095761.